关键词：哮喘；咳嗽；呼吸困难；胸闷；慢性疾病
摘 要：Asthma is a disease that affects the lungs and is characterized by wheezing, coughing, breathlessness, and chest tightness. It is a chronic ailment of the respiratory tract, caused by obstruction of the flow of air and bronchospasms.
目 录：

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Market Segmentation by Class of Drugs

07.1 Bronchodilators

07.2 Leukotriene Antagonists

07.3 Mast Cell Stabilizers

07.4 Immunosuppressants

07.5 Combination of LABA/ICS

08. Global Bronchodilators Market

08.1 Market Overview

08.2 Market Size and Forecast

09. Global Leukotriene Antagonists Market

09.1 Market Overview

09.2 Market Size and Forecast

10. Global Mast Cell Stabilizers Market

10.1 Market Overview

10.2 Market Size and Forecast

11. Global Immunosuppressants Market

11.1 Market Overview

11.2 Market Size and Forecast

12. Global Combination of ICS/LABA Market

12.1 Market Overview

12.2 Market Size and Forecast

13. Global Other Asthma Drugs Market

13.1 Market Overview

13.2 Market Size and Forecast

14. Geographical Segmentation

14.1 Global Asthma Market by Geographical

Segmentation 2013-2018

14.2 Asthma Market in US

14.2.1 Market Overview

14.2.2 Market Size and Forecast

14.3 Asthma Market in Russia

14.3.1 Market Overview

14.3.2 Market Size and Forecast

14.4 Asthma Market in India

14.4.1 Market Overview

14.4.2 Market Size and Forecast

15. Rate of Incidence and Prevalence

16. Buying Criteria

17. Market Growth Drivers

18. Drivers and their Impact

19. Market Challenges

20. Impact of Drivers and Challenges

21. Market Trends

22. Trends and their Impact

23. Vendor Landscape

23.1 Competitive Scenario

23.1.1 Key News

23.1.2 Mergers and Acquisitions

23.2 Market Share Analysis 2013

23.2.1 AstraZeneca

23.2.2 F. Hoffmann-La Roche

23.2.3 GlaxoSmithKline

23.2.4 Merck

23.2.5 Novartis

23.3 Other and Future Prominent Vendors

24. Pipeline Portfolio

25. Key Vendor Analysis

25.1 AstraZeneca

25.1.1 Key Facts

25.1.2 Business Description

25.1.3 Business Segmentation

25.1.4 Business Strategy

25.1.5 Business Segmentation by Revenue 2013

25.1.6 Business Segmentation by Revenue 2011-2013

25.1.7 Geographical Segmentation by Revenue

25.1.8 Recent Developments

25.1.9 SWOT Analysis

25.2 F. Hoffmann-La Roche

25.2.1 Key Facts

25.2.2 Business Overview

25.2.3 Business Segmentation by Revenue 2013

25.2.4 Business Segmentation by Revenue 2012 and 2013

25.2.5 Geographical Segmentation by Revenue 2013

25.2.6 Business Strategy

25.2.7 Recent Developments

25.2.8 SWOT Analysis

25.3 GlaxoSmithKline

25.3.1 Key Facts

25.3.2 Business Overview

25.3.3 Business Segmentation

25.3.4 Business Segmentation by Revenue 2012 and 2013

25.3.5 Sales by Geography

25.3.6 Pipeline Products

25.3.7 Business Strategy

25.3.8 Key Information

25.3.9 SWOT Analysis

25.4 Merck

25.4.1 Key Facts

25.4.2 Business Overview

25.4.3 Business Segmentation by Revenue 2013

25.4.4 Business Segmentation by Revenue 2012 and 2013

25.4.5 Geographical Segmentation by Revenue 2013

25.4.6 Business Strategy

25.4.7 Key Developments

25.4.8 SWOT Analysis

25.5 Novartis

25.5.1 Key Facts

25.5.2 Business Overview

25.5.3 Business Segmentation by Revenue 2013

25.5.4 Business Segmentation by Revenue 2012 and 2013

25.5.5 Sales by Geography

25.5.6 Business Strategy

25.5.7 Key Developments

25.5.8 SWOT Analysis

26. Other Reports in this Series